Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer
Ryo Otsuka(Hokkaido University), Masakazu Yamaguchi(Iwata City Hospital), Narikazu Boku(Tokyo Medical University), Atsuo Takashima(National Cancer Center Hospital East), Hidekazu Hirano(National Cancer Center Hospital East), Yoshitaka Honma(National Cancer Center Hospital East), Natsuko Okita(National Cancer Center Hospital East), Satoru Iwasa(Tokyo National Hospital), Yoshinori Makino(Tokyo National Hospital), Ken Kato(National Cancer Center Hospital East), Masatoshi Sekiguchi(Tokyo National Hospital), Hironobu Hashimoto(Tokyo National Hospital), Takako Yanai(Tokyo National Hospital), Hirokazu Shoji(National Cancer Center Hospital East)
Cited by 5
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600